Chinese COVID-19 Vaccine Gives Immune Response

Chinese COVID-19 Vaccine Gives Immune Response
Chinese COVID-19 Vaccine Gives Immune Response

Video: Chinese COVID-19 Vaccine Gives Immune Response

Отличия серверных жестких дисков от десктопных
Video: How Effective Is Sinovac? Inactivated Virus VS mRNA Vaccine | Talking Point | COVID-19 2023, February

MOSCOW, November 21 - Project "Russia-China: Main". An inactivated vaccine candidate for COVID-19, developed by the Chinese biopharmaceutical company Sinovac Biotech, has shown safety and the ability to create a rapid immune response in human studies, according to early and mid-term clinical trials, published in The Lancet Infectious Diseases.

The level of antibodies in vaccinated volunteers was lower than in those who successfully recovered from COVID-19. However, this did not affect the ability of the biological product to protect the human body from viral infection, the results of the studies indicate.

The CoronaVac vaccine was used in phases 1 and 2 in a double-blind, randomized, placebo-controlled study in over 700 healthy adults aged 18 to 59 years.

The participants were given 2 doses of the vaccine 14 days apart. The results indicate the effectiveness of the drug and its suitability for emergency use during a pandemic, said one of the authors of the scientific article, Zhu Fengcai.

He noted that more research remains to be done to determine the duration of the immune response after vaccination.

Currently, the vaccine candidate has entered the third phase of clinical trials to confirm its effectiveness.

The latest data on the situation with COVID-19 in Russia and the world are presented on the stopcoronavirus.rf portal

Popular by topic